Castle Biosciences shares are trading higher following a Medicare coverage policy reversal by Novitas related to DecisionDx.
Portfolio Pulse from Benzinga Newsdesk
Shares of Castle Biosciences are trading higher following a Medicare coverage policy reversal by Novitas related to DecisionDx.

July 07, 2023 | 7:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Castle Biosciences' stock is trading higher due to a Medicare coverage policy reversal by Novitas related to DecisionDx.
The Medicare coverage policy reversal by Novitas for DecisionDx is a positive development for Castle Biosciences. This could lead to increased usage of DecisionDx, potentially boosting the company's revenues and positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100